Individuals living with atopic dermatitis (AD), also known as eczema, face a heightened risk of experiencing depression and anxiety. This risk is further exacerbated when they also suffer from additional allergic symptoms. A recent study showcased at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting in Anaheim, California, reveals that out of those affected by AD, 72% encountered symptoms of poor mental health for between 1 to 10 days in the last month. In comparison, 17% experienced these symptoms for over 11 days.
“Allison Loiselle, PhD, the study’s lead author from the National Eczema Association, highlights the lack of awareness among those not afflicted by AD about its severe impact. The condition is not only about the intense itchiness and the discomfort of dry, cracked skin but also about the significant disturbances it causes to sleep and the broader deterioration in quality of life and overall well-being. The unpredictability and chronic nature of AD also contribute to the development of depression and anxiety among sufferers.
Of the 954 participants who participated in the survey, 23% consulted with an allergist as part of their treatment plan for eczema. Specifically, for 124 individuals (96 adults and 28 caregivers), an allergist was the primary care provider for their or their child’s eczema. The majority of respondents classified their current AD severity as mild (36%), and again, 72% reported experiencing poor mental health symptoms for 1 to 10 days in the last month, with 17% reporting such symptoms for more than 11 days. Notably, one-third (35%) of respondents had never discussed their mental health with their allergist, and 57% indicated that their allergist had never inquired about it. However, 45% mentioned that their allergist had referred them to mental health services or resources.
Tamara Hubbard, MA, LCPC, a counsellor specializing in assisting parents of children with allergies and asthma and a member of the ACAAI Public Relations Committee (not involved in the study), emphasizes the severe challenges of living with AD. The constant itching and concern over the impact on one’s appearance can be overwhelming. The repercussions of AD on quality of life are substantial, leading to social withdrawal, emotional and behavioural issues, and severe psychological distress, including depression, anxiety, and thoughts of suicide. Hubbard stresses the importance of open communication between patients and healthcare providers regarding mental health issues and the necessity of being informed about available resources and mental health professionals who can offer assistance. Engaging with an allergist to explore treatments that mitigate the effects of AD, in tandem with support from a mental health professional, can significantly alleviate the emotional and psychological burden of AD.”
More information: A. Loiselle et al, Atopic dermatitis patient experience with discussing and addressing mental health concerns with allergists, Annals of Allergy Asthma & Immunology. DOI: 10.1016/j.anai.2023.08.278
Journal information: Annals of Allergy Asthma & Immunology Provided by American College of Allergy Asthma and Immunology
